Postherpetic Neuralgia
📧 Sign up to get email alerts when something new happens for Postherpetic Neuralgia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2020-09-29FDA Approved: GABAPENTIN — Supplemental Application (ScieGen Pharmaceuticals, Inc.)
FDA approved a supplemental application for Gabapentin from ScieGen Pharmaceuticals, Inc.
-
FDA approval · 2020-09-16FDA Approved: GABAPENTIN — Supplemental Application (ACI Healthcare USA, Inc.)
FDA approved a supplemental application for gabapentin from ACI Healthcare USA, Inc., updating the regulatory status of the product.
-
FDA approval · 2020-09-08FDA Approved: GABAPENTIN — Supplemental Application (Exelan Pharmaceuticals, Inc.)
FDA approved a supplemental application for gabapentin from Exelan Pharmaceuticals, Inc. under an ANDA.
-
FDA approval · 2020-08-21FDA Approved: GABAPENTIN — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approved a supplemental application for gabapentin from Amneal Pharmaceuticals LLC.
-
FDA approval · 2020-08-17FDA Approved: GABAPENTIN — Original Application (Zhejiang Yongtai Pharmaceutical Co., Ltd)
FDA approved the original application for gabapentin from Zhejiang Yongtai Pharmaceutical Co., Ltd., authorizing a generic gabapentin produc…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2020-08-07FDA Approved: GABAPENTIN — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for gabapentin from Sun Pharmaceutical Industries, Inc., granting supplemental approval for this…
-
FDA approval · 2020-07-28FDA Approved: GABAPENTIN — Supplemental Application (Granules Pharmaceuticals Inc)
FDA approved a supplemental application for gabapentin submitted by Granules Pharmaceuticals Inc.
-
FDA approval · 2020-04-17FDA Approved: HORIZANT — Supplemental Application (Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals))
The FDA approved a supplemental application for Horizant (gabapentin enacarbil) submitted by Azurity Pharmaceuticals (formerly Arbor Pharmac…
-
FDA approval · 2020-04-03FDA Approved: LYRICA CR — Supplemental Application (Viatris Specialty LLC)
FDA approved a supplemental NDA for LYRICA CR (pregabalin) submitted by Viatris Specialty LLC, indicating a regulatory approval of a supplem…
-
FDA approval · 2020-04-02FDA Approved: HORIZANT — Supplemental Application (Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals))
FDA approved a supplemental application for HORIZANT (gabapentin enacarbil) submitted by Azurity Pharmaceuticals, Inc. (formerly Arbor Pharm…
-
FDA approval · 2020-04-02FDA Approved: NEURONTIN — Supplemental Application (Parke-Davis Div of Pfizer Inc)
The FDA approved a supplemental application for Neurontin (gabapentin) by Parke-Davis Div of Pfizer Inc, authorizing changes to its labeling…
-
FDA approval · 2020-03-25FDA Approved: GABAPENTIN — Supplemental Application (Ascend Laboratories, LLC)
FDA approved a supplemental application for gabapentin submitted by Ascend Laboratories, LLC. The approval updates the generic gabapentin pr…
-
FDA approval · 2020-03-20FDA Approved: PREGABALIN — Original Application (Chartwell RX, LLC)
FDA approves Chartwell RX, LLC's original ANDA for pregabalin, establishing a generic version of the drug.
-
CLINICAL_TRIALS trial_result · 2020-01-07Clinical Trial Update: A Safety and Efficacy Study of AGN-214868 in Patients With Postherpetic Neuralgia [Phase 2]
Phase 2 trial update for AGN-214868 in postherpetic neuralgia; study terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2019-12-09Clinical Trial Update: The Efficacy of MK-8291 in Participants With Post-herpetic Neuralgia (PHN) With Allodynia (MK-8291-012) [Phase 1]
Phase 1 trial evaluating MK-8291 for postherpetic neuralgia has completed with results posted in 2019.
-
FDA approval · 2019-12-03FDA Approved: GABAPENTIN — Original Application (American Health Packaging)
The FDA approved the original application for gabapentin from American Health Packaging, enabling a generic version of the anticonvulsant.
-
FDA approval · 2019-11-29FDA Approved: PREGABALIN — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approved the original ANDA for pregabalin from Sun Pharmaceutical Industries, authorizing a generic version of pregabalin.
-
CLINICAL_TRIALS trial_result · 2019-10-09Clinical Trial Update: Efficacy and Safety of Topical Versus Systemic Treatment in Postherpetic Neuralgia and Diabetic Polyneuropathic Pain [Phase 3]
Phase 3 trial update comparing topical versus systemic treatment for postherpetic neuralgia and diabetic polyneuropathic pain shows efficacy…
-
FDA approval · 2019-10-08FDA Approved: PREGABALIN — Original Application (Camber Pharmaceuticals, Inc.)
The FDA approved Camber Pharmaceuticals' original Abbreviated New Drug Application for pregabalin, a generic version of the brand product.
-
FDA approval · 2019-07-19FDA Approved: PREGABALIN — Original Application (Cipla USA, Inc.)
FDA approves Cipla USA, Inc.'s original application for pregabalin, granting a generic version of the drug for its established indications.
-
FDA approval · 2019-07-19FDA Approved: PREGABALIN — Original Application (ScieGen Pharmaceuticals, Inc)
FDA approves ScieGen Pharmaceuticals' original application for pregabalin (generic pregabalin), enabling the generic product to be marketed …
-
FDA approval · 2019-07-19FDA Approved: PREGABALIN — Original Application (AvPAK)
FDA approved AvPAK's original application for pregabalin, enabling the generic version to enter the market.
-
FDA approval · 2019-07-19FDA Approved: PREGABALIN — Original Application (Rising Pharma Holdings, Inc.)
FDA approved the original application for pregabalin (generic) submitted by Rising Pharma Holdings, Inc., authorizing its market authorizati…
-
FDA approval · 2019-07-19FDA Approved: PREGABALIN — Original Application (Ascend Laboratories, LLC)
FDA approved Ascend Laboratories' generic pregabalin under ANDA207623 (original application), providing a generic version of pregabalin.
-
FDA approval · 2019-07-19FDA Approved: PREGABALIN — Original Application (Alembic Pharmaceuticals Inc.)
The FDA approved Alembic Pharmaceuticals' original ANDA for pregabalin, enabling a generic version of pregabalin to be marketed. The approva…